Introduction {#sec1-1}
============

Human herpesviruses are known to cause vastly different diseases/illnesses that range from mild oral-facial blisters and chicken pox to fatal conditions such as Burkitt's lymphoma and Kaposi's sarcoma ([@r3]; [@r13]; [@r56]). Herpesviruses are large DNA viruses that share an overall common virion structure. The virion consists of a dsDNA encapsidated within an icosahedral capsid ([@r13]). Between the capsid and the outer membrane lies a layer of proteins, collectively known as the tegument ([@r24]). Twenty-four different tegument proteins have been identified in *Herpes simplex virus 1* (HSV-1; *Human herpesvirus 1*) but, judging from sequence alignments, only a third of them are conserved across all the subfamilies (*Alpha*-, *Beta*- and *Gammaherpesvirinae*) of the family *Herpesviridae* ([@r30]). Tegument proteins can occur in several thousands of copies inside the virion, whilst others are less abundant ([@r15]). Some tegument proteins have been found to contribute greatly to viral entry, assembly and egress, whilst others play vital roles in viral immune evasion and regulation of viral gene expressions ([@r29]; [@r30]; [@r46]).

VP22 is a highly abundant tegument protein in HSV-1 that has been suggested, based on sequence analysis, to be unique to the alphaherpesviruses. VP22 has been suggested to be important for the secondary tegumentation of the virion and the accurate localization of several important herpesviral proteins, including the transcription activating protein VP16, the outer capsid protein VP26, the interesting E3 ubiquitin ligase ICP0, the major transcriptional regulatory protein ICP4 and the essential multifunctional ICP27 ([@r8]; [@r15]; [@r21]; [@r34]; [@r44]; [@r50]; [@r58]). Recently, VP22 has emerged as a key node in the HSV-1 tegument--glycoprotein network, where it makes multiple protein--protein interactions and plays a selective role in the tegument acquisition of viral glycoproteins gE, gD and gM ([@r10]; [@r18]; [@r21]; [@r25]; [@r35]; [@r39], [@r41]; Potel & Elliott, 2005; [@r49]). VP22 also binds directly to cellular proteins like chromatin remodelling protein (TAF-1) and non-muscle myosin II (NMII) ([@r53], [@r54]). It has also been associated with interactions with cellular membranes, microtubules and nucleic acids ([@r8]; [@r16]; [@r36]; [@r47]). Interestingly VP22 exhibits transfection potential and has been used successfully in several studies to target therapeutic DNA to specific cells of interest, such as stem cells ([@r6]; [@r17]; [@r28]; [@r32]).

Sequence analysis and secondary structure predictions reveal that VP22 consists of a non-conserved N-terminal domain and a conserved C-terminal domain with the clear presence of secondary structures ([@r39]). Deletion and functional studies have shown that the conserved C-terminal domain in VP22 is important for binding to VP16 and gE ([@r39], [@r40]). To generate insight into the VP22 structure and function, we crystallized and solved the structure of the conserved C-terminal domain of this protein, hereafter referred to as VP22~core~, to a resolution of 1.9 Å. VP22~core~ exists as a dimer with a highly conserved dimerization site. Although sequence homology of VP22 has only been established within the alphaherpesviruses, the crystal structure reveals that it shares extensive structural similarity with ORF52 from *Murid herpesvirus 68* (MHV-68) (subfamily *Gammaherpesvirinae*). ORF52~MHV-68~ has been found to be essential for replication in MHV-68 *in vitro* ([@r48]). Similar to VP22~core~, ORF52~MHV-68~ is also a highly expressed tegument protein that exists as a dimer made up of two identical monomers ([@r5]; [@r7]). It is well conserved within the gammaherpesviruses, and has been implicated to be important for tegument association and interactions ([@r7]; [@r23]; [@r45]; [@r51]). These are coincidentally similar to some of the proposed functions of VP22 ([@r8]; [@r21]). With the VP22~core~ structure in hand, we have been able to compare the two protein structures, revisit the outcome of reported mutational studies as well as identify completely conserved residues that might be important for function.

Results and Discussion {#sec1-2}
======================

Structure of VP22~core~ {#sec2-1}
-----------------------

VP22~core~ crystallized in the space group P6~1~22 and the crystal structure \[Protein Data Bank (PDB) ID: 4XAL\] was determined at a resolution of 1.87 Å using single isomorphous replacement with anomalous scattering (SIRAS). Each asymmetrical unit consists of a molecule of VP22~core~, with visual electron density for residues 174--260, together with three amino acids from the N-terminal purification tag. The crystallographic data statistics are summarized in [Table 1](#t1){ref-type="table"}. The structure of VP22~core~ is constituted by a long central α-helix (α1) flanked by a long random coil (L1) at the N terminus, two shorter α-helices (α2 and α3) and one β-strand (β1) at the C terminus ([Fig. 1](#f1){ref-type="fig"}). Two VP22~core~ monomers are related by the crystallographic twofold axis and are slightly twisted around each other, creating an elongated dimer ([Fig. 1](#f1){ref-type="fig"}) where the α1 helices and the β1 interact in an anti-parallel fashion. The dimeric state of VP22~core~ has been proposed previously ([@r37]) and our light-scattering results show that VP22~core~ is mono-dispersed with a mean molar mass of \~26 500 g mol^−1^. This is roughly twice the theoretical molecular mass of the monomeric VP22~core~ including the purification tag and the tobacco etch virus (TEV) protease site (14 551 g mol^−1^), further confirming that VP22~core~ is a dimer in solution ([Fig. 2](#f2){ref-type="fig"}).

###### Summary of data collection, phasing and refinement statistics

  Parameter                                            Native (PDB ID: 4XAL)                  Soaked with PbCl~2~
  -------------------------------------------- ------------------------------------- -------------------------------------
  X-ray source                                              NSRRC 13C1                            NSRRC 13C1
  Wavelength (Å)                                              0.9762                                0.9762
  Space group                                                 P6~1~22                               P6~1~22
  Unit cell parameters                          *a* = 65.0, *b* = 65.0, *c* = 107.9   *a* = 65.0, *b* = 65.0, *c* = 107.6
                                                      α = 90, β = 90, γ = 120               α = 90, β = 90, γ = 120
  Resolution range (Å)                              30.00--1.87 (1.94--1.87)\*            27.80--1.87 (1.94--1.87)\*
  *I*/σ(*I*)                                               24.3 (3.2)\*                          43.8 (5.81)\*
  Completeness (%)                                         99.0 (99.6)\*                          100 (97.6)
  Redundancy                                                2.9 (2.8)\*                           10.2 (10.2)
  *R* ~sym~†                                               0.052 (0.289)                         0.047 (0.188)
  Total reflections                                           182 439                               194 305
  Unique reflections                                          11 745                                11 789
  **AutoSol**                                                                        
  No. of sites                                                                                         1
  Initial figure of merit                                                                            0.21
  Figure of merit after density modification                                                         0.63
  **Refinement**                                                                     
  *R* ~factor~‡/*R* ~free~§ (%)                              20.8/25.1               
  Atoms                                                         828                  
  Protein residues                                              96                   
  Solvent molecules                                             74                   
  RMSD bonds (Å)                                               0.027                 
  RMSD angles (°)                                              0.77                  
  **Ramachandran quality plot**                                                      
  In preferred region (%)                                       99                   
  In allowed region (%)                                          1                   
  Outliers (%)                                                   0                   

NSRRC, National Synchrotron Radiation Research Center (Taiwan, ROC).

Values within parentheses represent the highest resolution shell (1.939--1.872 Å).

*R* ~sym~ = 100×∑(\|*I~j~*−\[*I*\]\|)/∑(\|*I*\|), where the sum is calculated over all observations of a measured reflection (*I~j~*) and \[*I*\] is the mean intensity of all the measured observations (*I~j~*).

*R* ~factor~ = 100×∑(\|*F* ~o~\|−\|*F* ~c~\|)/∑(\|*F* ~o~\|), where *F* ~o~ and *F* ~c~ are the observed and calculated structure factors, respectively.

*R* ~free~ is equivalent to *R* ~factor~, but where 5 % of the measured reflections have been excluded from refinement and set aside for cross-validation.

![Different views of the crystal structure of the VP22~core~ dimer. (a) Each monomer (coloured red and blue) consists of three α-helices (α1--α3) and one β-strand (β1). The monomers of VP22~core~ coil around each other. The flat β1 from both monomers create a plateau with a conserved arginine (Arg242) sticking up like a peak. We refer to this face of the protein as the 'peak side'. (b) A 90° rotation of the dimer gives the top view of the peak side. (c) The opposite side reveals a groove that is created by L1 and α1 from both monomers. (d) A 90° rotation of the dimer gives the top view of the groove side.](vir-96-06-1436-g001){#f1}

![Light-scattering curve of VP22~core~ in solution as a function of its elution volume. The monomeric molar mass of VP22~core~ is 14551 g mol^−1^ and the light-scattering results show that VP22~core~ is mono-dispersed with an estimated mean molar mass of 26 500±5000 g mol^−1^. This shows that VP22~core~ is dimeric in solution. The SDS-PAGE gel of the injected VP22~core~ sample and the protein ladder (Mark12 Unstained Standard; kDa) is displayed on the left of the elution peak.](vir-96-06-1436-g002){#f2}

To be able to orientate ourselves in the structure, we have dubbed one side of the dimer the 'peak' ([Figs 1a, b](#f1){ref-type="fig"} and [3a](#f3){ref-type="fig"}) and the other side the 'groove' ([Figs 1c, d](#f1){ref-type="fig"} and [3b](#f3){ref-type="fig"}). On the peak side, the dimerization of β1 creates a flat plateau where two conserved arginines (Arg242) create a positively charged peak in the middle of a less charged area ([Figs 1a](#f1){ref-type="fig"} and [3a, c](#f3){ref-type="fig"}). Flanking the sides of this peak are two identical negatively charged patches. The residues that contributed to these two patches are Asp186 from L1 of one VP22~core~ monomer and a cluster of negatively charged residues, Glu230, Asp231 and Glu234, from α2 of the other monomer ([Figs 1c](#f1){ref-type="fig"} and [3a, d](#f3){ref-type="fig"}). The electrostatic potential surface map of the groove, which is created by L1 and α1 from both monomers, shows two large and positively charged patches. In general, distinctly charged patches on a protein surface might indicate potential sites for protein--protein interactions and any of these described areas in VP22~core~ could serve this purpose.

![Electrostatic potential surface maps of the VP22~core~ dimer. (a) The positive, negative and uncharged regions of the surface map are coloured blue, red and white, respectively. The protein is shown in the same orientation as in [Fig. 1(b)](#f1){ref-type="fig"}. It reveals a patch of positive charges in the middle of a relatively uncharged surface. Flanking their sides are areas of negatively charged patches. (b) At the groove side, there are two large positively charged patches. The charges on this surface are contributed by the α1 amino acids lining the groove. The protein is shown in the same orientation as in [Fig. 1(d)](#f1){ref-type="fig"}. (c) The positively charged patch at the peak side is created by Arg242, whilst (d) the negatively charged patch is created by Asp186 from L1 of one monomer and a cluster of negatively charged residues, Glu230, Asp231 and Glu234, from α2 of the second monomer. These distinctively charged patches on VP22~core~ might be potential molecular interaction sites.](vir-96-06-1436-g003){#f3}

Interestingly, we observed a stretch of unaccounted electron density next to β1 ([Fig. 4](#f4){ref-type="fig"}). The β1 β-sheet forms a tiny β-sheet through interactions with β1 from the other monomer and contributes to the overall dimerization of VP22~core~. We managed to model a six-amino-acid peptide into this density. This peptide forms a perfect β-strand, expanding the β1 β-sheet to four stands. It corresponds to the sequence SSGSVD, which is a part of the linker region between the N-terminal His~6~-tag and the TEV protease cleavage site. This peptide is most likely contributed *in trans* from a neighbouring subunit in the crystal lattice, which is not part of the crystallographic dimer. The peptide is held tightly into place by backbone interactions and the coordination of the hydroxyl group on the N-terminal serine. Although this particular peptide sequence is most likely not of biological relevance, it indicates directly that this peptide-binding cavity could constitute a real site for protein interaction with VP22. A motif similar to the peptide was not identified at the N terminus of VP22, but it is plausible that some as-yet unidentified part of the N terminus could form a β-strand and bind in this location.

![Peptide-binding site of VP22~core~ with the electrostatic potential surface map of the peak side. A peptide consisting of six amino acids was traced from the stretch of unmodelled electron density next to β1. The interaction between the peptide (yellow) and β1 (white) is magnified and displayed below. The peptide fits well into the electron density and the sequence was traced to be SSGSVD. Hydrogen bonds hold the peptide to β1 and these interactions are illustrated by yellow dotted lines.](vir-96-06-1436-g004){#f4}

Conserved residues in VP22~core~ contribute to its fold, oligomerization and interactions {#sec2-2}
-----------------------------------------------------------------------------------------

VP22 has many proposed interaction partners. In order to evaluate and differentiate between these interactions, various deletion mutants have been created, described and discussed ([@r8]; [@r19]; [@r25]; [@r36]; [@r39], [@r40], [@r41]; [@r49]) (summarized in Table S1, available in the online Supplementary Material). Whilst these studies have laid a foundation for the VP22 protein interaction network, the crystal structure of VP22~core~ can now aid in understanding these interactions at the atomic level. We mapped several of the published mutations onto the VP22~core~ structure to gain more insights into their structure--function relationship.

Upon mapping these deletions and truncations, we can now see that most of the mutated residues that yielded in a loss of protein function are located in L1, α1 or α2 (Table S1). In most cases, the reported deletions would have removed parts of the long central helix α1 -- a key secondary structure along the dimerization interface. Most of the described point mutations that seem to have an effect on VP22 interactions are also focused on this helix ([@r40], [@r41]; [@r50]). In particular, Trp189, Phe201 and Trp221, which have been found to disrupt the binding between VP22 and gE/VP16, are located along the dimerization interface of α1 ([Fig. 5a, b](#f5){ref-type="fig"}). It is possible that most effects observed in these studies are the result of the distortion of VP22's dimerization, rather than specific functional effects.

![Point mutations mapped in VP22~core~. The mapped residues (a) Trp189/Phe201, (b) Trp221, (c) Phe196 and (d) Leu245/Leu246 were found to be important for VP22 protein interactions by [@r41]; (a, b, d) show one VP22~core~ monomer displayed as a cartoon and the other monomer displayed as the electrostatic potential surface map. (a) Trp189/Phe201 and (b) Trp221 are buried in the hydrophobic dimerization interface, rendering them unlikely to participate in any specific protein--protein interactions. Instead, they seem very important for dimerization. However, the surface electrostatic potential map shows that the conserved Phe196 (c) is found on the surface of the VP22~core~ and is likely to participate in protein--protein interactions. However, Leu245/Leu246 (d) are buried in the hydrophobic interface, indicating that the leucine pair is not likely to participate in specific protein--protein interactions.](vir-96-06-1436-g005){#f5}

A residue of particular interest is the conserved and solvent-exposed Phe196. The electrostatic surface potential of VP22~core~ reveals that this hydrophobic Phe196 is located in the middle of the two large and highly positively charged patches at the groove side ([Fig. 5c](#f5){ref-type="fig"}). With a single point mutation of this amino acid, [@r41] were able to remove the binding between gE and VP22, but not between VP16 and VP22. Moreover, conserved aromatic residues on the surface of a protein have often been shown to be important for protein interactions ([@r2]; [@r9]; [@r11]; [@r22]). The functional evidence from [@r41], in combination with the high degree of conservation and strategic location/orientation of Phe196, suggest its importance in protein interactions. Given that the point mutation on Phe196 only removed the binding between gE and VP22, Phe196 and the surrounding amino acid residues may also play a key role in discriminating between the different interacting proteins of VP22 ([@r41]).

Similarly, the binding between VP22 and VP16 was disrupted when a pair of conserved leucines along α2~VP22~ (Leu235 and Leu236) was mutated into alanines ([@r40]). These mutations also altered the localization sites of several HSV-1 proteins, including ICP0, gE, gD, VP16 and vhs, in the host cell ([@r50]). However, these leucines are exposed to the hydrophobic core and do not appear to be able to participate in any direct protein--protein interactions ([Fig. 5d](#f5){ref-type="fig"}). Thus, the loss of protein function may likely have arisen due to either the collapse of the global VP22~core~ structure or local distortions of α-helical stability/positions. If the observed effects are indeed a result of local structural distortions, these mutations highlight the significance of the entire α2 for making interactions with its binding partners.

VP22~core~ is structurally homologous to ORF52 from MHV-68 {#sec2-3}
----------------------------------------------------------

VP22 consists of two domains where only the C-terminal domain is highly conserved in the alphaherpesviruses. The N-terminal domain is more variable and this domain is completely absent in some alphaherpesviruses ([@r39]). A structural homology search with the structure of VP22~core~ on the Dali server identified another herpesvirus protein, ORF52 from MHV-68 (PDB ID: 2R3H and 2OA5), with a mean *Z* score of 5.6 ([@r27]). ORF52 from MHV-68 (ORF52~MHV-68~) is a small viral protein of 21 kDa, making it substantially smaller than the full-length VP22 (35 kDa). As with VP22~core~, ORF52~MHV-68~ is also a highly expressed tegument protein that exists as a dimer made up of two identical monomers ([@r5]; [@r7]). Both VP22 and ORF52~MHV-68~ are well conserved within the alpha- and gammaherpesviruses, respectively, and both proteins seem to share similar functions, such as tegument association and interactions ([@r7]; [@r8]; [@r23]; [@r45]; [@r51]). For clarity, we use the subscripts 'VP22' and 'ORF52' to differentiate between the secondary structural elements in the respective proteins.

To analyse the structural similarities in detail, the VP22~core~ structure was compared with the published dimer of ORF52~MHV-68~ (PDB ID: 2OA5) using Coot ([@r20]). The α carbons of each VP22~core~ monomer and the individual ORF52~MHV-68~ monomer align well with a mean root-mean-square deviation (RMSD) of 2.1 Å ([Fig. 6a, b](#f6){ref-type="fig"}). Both VP22~core~ and ORF52~MHV-68~ have long central α-helices (α1~VP22~ and α2~ORF52~) that constitute the core of the dimer interactions. The anti-parallel β-strands (β1~VP22~ and β1~ORF52~) also contribute to this dimerization. The helices α2~VP22~ and α3~ORF52~ located on the surface of the proteins align well with each other. There is a slight difference at the C terminus of this superposition where we notice that whilst ORF52~MHV-68~ has an extended loop, HSV-1 VP22~core~ has an α-helix denoted α3~VP22~. However, the major differences between VP22~core~ and ORF52~MHV-68~ lie at the N terminus ([Fig. 6a, b](#f6){ref-type="fig"}). At the N terminus, ORF52~MHV-68~ has an additional helix (α1~ORF52~), whilst VP22~core~ has a long extended loop (L1~VP22~). In ORF52~MHV-68~, this particular helix displays two different conformations by extending in different directions in the dimer structure, suggestive of a flexible N terminus in ORF52~MHV-68~. L1~VP22~ stretches in the same direction as α1~ORF52~ in chain A and in the opposite direction from α1~ORF52~ of ORF52~MHV-68~ chain B. VP22~core~ has an additional N-terminal domain, not present in our structure, and secondary structure predictions also indicate a low α-helical propensity along L1~VP22~ (not shown) ([@r12]). Thus, there is a possibility that L1~VP22~ exists as a part of a long and flexible connection between VP22~core~ and its N-terminal domain.

![Structural and sequence alignment of VP22~core~ and ORF52~MHV-68~. The dimer structures of (a) VP22~core~ and (b) ORF52~MHV-68~ are shown as cartoons in the same orientation. (c) The structural alignment of VP22~core~ and ORF52~MHV-68~ is reproduced in a sequence alignment. The completely conserved amino acids are highlighted in red, whilst the other conserved residues are highlighted in pink. The conserved amino acids are mainly concentrated along the hydrophobic dimerization interface at α1~VP22~, α2~VP22~ and β1~VP22~.](vir-96-06-1436-g006){#f6}

Based on the structural similarity, we generated a structure-based sequence alignment between the monomeric VP22~core~ and ORF52~MHV-68~ yielding a sequence identity of 13 % ([Fig. 6c](#f6){ref-type="fig"}) ([@r43]). As with the conserved residues within the VP22 homologues, most of these residues are clustered throughout the dimerization interface and the hydrophobic core. The structure-based sequence alignment prompted us to try and identify a possible homologue in the betaherpesviruses. However, no homologue could be identified.

To further understand the sequence conservation between the alpha- and gammaherpesviruses, we generated an additional alignment with most homologues from the alpha- and gammaherpesviruses (Fig. S1). Although this sequence alignment displays very low sequence similarity, it does reveal four amino acids that are particularly conserved in both subfamilies. In particular, along α2~VP22~ and α3~MHV-68~, a leucine (Leu236~VP22~/Leu89~ORF52~) is conserved in both the alpha- and gammaherpesviruses. As in VP22, this conserved leucine in ORF52~MHV-68~ (coloured red at α3~MHV-68~ in [Fig. 6b](#f6){ref-type="fig"}) is also exposed to the hydrophobic core of the protein, supporting the importance of oligomerization of this protein for proper function.

The remaining three amino acids that are conserved in both the alpha- and gammaherpesviruses are Arg242~VP22~/Arg95~ORF52~, Val243~VP22~/Val96~ORF52~ and Val245~VP22~/Val98~ORF52~ (Fig. S1). These amino acids are located along β1, where the side chain of the valines stretches into the core of the structure, whilst the side chain of the arginine is solvent-exposed ([Figs 4](#f4){ref-type="fig"} and [6](#f6){ref-type="fig"}). The two conserved valines seem to contribute to the fold, but the highly conserved arginine (Arg242~VP22~/Arg95~ORF52~) along β1 appears to be important for protein binding. This conserved residue is found next to our proposed peptide-binding site and is what creates the distinct peak of VP22~core~ ([Figs 3a, c](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}). To underline the importance of this completely conserved arginine is the fact that [@r55] could disrupt the binding between ORF52~MHV-68~ and ORF42~MHV-68~ with a single amino acid substitution (Arg→Ala) in this position. Hence, although there is no determined homologue to ORF42~MHV-68~ in HSV-1, it is likely that the corresponding mutation in VP22 could also disrupt the interaction to one or several of its (un)known binding partners. It would be interesting to see how a mutation of this conserved Arg242~VP22~ would affect this protein *in vivo*.

The described conserved structural features and functions of VP22 and ORF52~MHV-68~ suggest that both proteins could act as protein adaptors in which different proteins are bound. Moreover, being a major tegument protein in HSV-1, VP22 has been associated with multiple protein--protein interactions, several HSV-1 protein localizations as well as protein transportation along the microtubules ([@r10]; [@r18], [@r19]; [@r16]; [@r21]; [@r25]; [@r31]; [@r34]; [@r35]; [@r36]; [@r39], [@r41]; [@r44]; [@r49]; [@r50]; [@r57]). It is likely that VP22 and the structural homologue ORF52~MHV-68~ could be involved in assembling a protein scaffold consisting of other tegument proteins, thereby creating a protein bridge between the capsid and the lipid envelope. This assembly may be important for the intracellular transportation of proteins along the microtubules.

In conclusion, with a three-dimensional structure of a well-studied protein like VP22, we can now start connecting functional data with structural information. We hope that the data presented in this paper might help to spur new and directed efforts to elucidate this protein's function. The unexpected structural similarities between VP22 and ORF52~MHV-68~ may contribute to further functional studies of other herpesviral proteins and pose intriguing questions about the evolutionary relationship of the different herpesvirus subfamilies.

Methods {#sec1-3}
=======

 {#sec2-4}

### Cloning and protein expression. {#sec3-1}

The VP22~core~ (residues 174--281) (GenBank accession number BAE87004.1) was cloned into the plasmid pNIC28-Bsa4 (GenBank accession number EF198106) containing a His~6~-tag and a TEV protease site at the N terminus. Cloning and protein expression of the VP22~core~ were performed as described previously ([@r26]). The purification of VP22~core~ was performed as follows. The bacterial cells expressing VP22~core~ were pelleted and resuspended in lysis buffer (100 mM HEPES, pH 8.0, 500 mM NaCl, 10 mM imidazole pH 8.0, 10 % glycerol, 0.5 mM TCEP \[Tris(2-carboxyethyl)phosphine\], 0.1 mg lysozyme ml^−1^, 1 ml protease inhibitor ml^−1^ and 25 U Benzonase). Lysates were clarified and loaded on a 1 ml HisTrap HP column (GE Healthcare). The column was washed with 20 ml wash buffer (20 mM HEPES, pH 7.5, 500 mM NaCl, 10 mM imidazole, pH 7.5, 10 % glycerol and 0.5 mM TCEP) and 10 ml second wash buffer (20 mM HEPES, pH 7.5, 500 mM NaCl, 25 mM imidazole, pH 7.5, 10 % glycerol and 0.5 mM TCEP) before eluting with 5 ml elution buffer (20 mM HEPES, pH 7.5, 500 mM NaCl, 500 mM imidazole, pH 7.5, 10 % glycerol and 0.5 mM TCEP). The eluted sample was loaded on a pre-equilibrated (20 mM HEPES, pH 7.5, 300 mM NaCl, 10 % glycerol and 0.5 mM TCEP) size-exclusion column (HiLoad 16/60 Superdex 75; GE Healthcare) and eluted in 2 ml fractions. The fractions were accessed for purity on a SDS-PAGE gel and only pure fractions containing our target protein were pooled. TCEP (2 mM) was added to the pooled sample and the protein was further concentrated to 12 mg ml^−1^ before storing at −80 °C.

### Crystallization and data collection. {#sec3-2}

Native crystals of VP22~core~ were obtained from a sitting drop experiment with drops containing 1.5 µl purified VP22~core~ protein (12 mg VP22~core~ ml^−1^) and 1.5 µl reservoir solution (40 % PEG 300 and 0.1 M phosphate citrate, pH 5) was incubated with 300 µl reservoir solution in a 24-wells sitting drop Intelli-plate (Art Robbins) at 20 °C. Native crystals were transferred to a fresh drop of reservoir solution containing 1 mM PbCl~2~ for 45 min to obtain derivative crystals. No additional cryoprotectant was added to the native and the derivative crystals before flash freezing them in liquid nitrogen.

Diffraction datasets were collected at beamline BL13C1 at the National Synchrotron Radiation Research Center (Taiwan, ROC) with the detector ADSC Quantum-315r CCD. Datasets were collected at 0.97 Å, and integrated and scaled with [hkl]{.smallcaps}-2000 ([@r42]).

### Structural determination. {#sec3-3}

The initial crystallographic model of VP22~core~ was obtained with SIRAS using AutoSol wizard and AutoBuild from the [phenix]{.smallcaps} suite ([@r1]). The final structure was obtained after many cycles of automatic and manual structural refinement with [refmac]{.smallcaps} ([@r38]) and Coot ([@r20]). The structure refinement was validated with [sfcheck]{.smallcaps} ([@r52]) and the geometry of the final structure was analysed with [rampage]{.smallcaps} ([@r33]).

The figures of the final VP22~core~ structure were created and displayed with PyMOL ([http://www.PyMOL.org/](http://www.pymol.org/)). The electrostatic potential of the solvent accessible surfaces of the protein were calculated using [pdb]{.smallcaps}2[pqr]{.smallcaps} ([@r14]) and the [apbs]{.smallcaps} plugin ([@r4]) in PyMOL. The electrostatic potential contour levels were set at ±3 *kT*/*e* and the surface maps were displayed with PyMOL.

### Structure-based sequence alignment. {#sec3-4}

The sequence alignment between VP22~core~ and ORF52~MHV-68~ was generated with a pair-wise structure-based alignment between the monomers using Chimera ([@r43]). Sequences of the VP22~core~ and ORF52~MHV-68~ homologues from the alpha- and gammaherpesviruses were aligned by adding their amino acid sequences to the structure-based alignment. The amino acid conservation was mapped and displayed with PyMOL.

### Multi-angle light scattering. {#sec3-5}

Light-scattering data were obtained with analytical size-exclusion chromatography (Superdex 200 5/150 GL; GE Healthcare) coupled with a multi-angle light-scattering detector (MiniDAWN TREOS; Wyatt Technology) and a refractive index detector (Optilab rEX; Wyatt Technology) on an ÄKTAmicro (GE Healthcare). An aliquot of 20 µl VP22~core~ (6 mg VP22~core~ ml^−1^) was injected onto the pre-equilibrated column (20 mM HEPES, pH 7.5, 300 mM NaCl, 10 % glycerol and 2 mM TCEP) at a flow rate of 0.3 ml min^−1^. [astra]{.smallcaps} 6 (Wyatt Technology) was used to determine the experimental protein molecular mass from the light-scattering data.
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One supplementary table and one supplementary figure are available with the online Supplementary Material.
